Cargando…
Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor
Ubiquilin-4 (UBQLN4) is a proteasomal shuttle factor that directly binds to ubiquitylated proteins and delivers its cargo to the 26S proteasome for degradation. We previously showed that upregulated UBQLN4 determines the DNA damage response (DDR) through the degradation of MRE11A. However, the regul...
Autores principales: | Kobayashi, Yuta, Bustos, Matias A., Shoji, Yoshiaki, Jachimowicz, Ron D., Shiloh, Yosef, Hoon, Dave S. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600423/ https://www.ncbi.nlm.nih.gov/pubmed/36291176 http://dx.doi.org/10.3390/cells11203311 |
Ejemplares similares
-
Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma
por: Murakami, Tomohiro, et al.
Publicado: (2021) -
UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
por: Shoji, Yoshiaki, et al.
Publicado: (2022) -
Short N-terminal disordered regions and the proline-rich domain are major regulators of phase transitions for full-length UBQLN1, UBQLN2 and UBQLN4
por: Dao, Thuy P., et al.
Publicado: (2023) -
Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma
por: Luo, Yuan‐Deng, et al.
Publicado: (2020) -
Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
por: Wang, Shaoteng, et al.
Publicado: (2020)